营养支持有助于改善心脏功能和心房患者的营养状况,这些患者正在接受埃斯莫洛尔化治疗
Xiaochao Liu1, Yulong Fan2, Zhi Liu1
1Department of Emergency, Xuanwu Hospital Capital Medical University, Beijing, China.
Frontiers in cardiovascular medicine
|December 22, 2025
概括
将营养护理与埃斯莫洛尔化相结合,可显著改善心脏功能,营养状况和心房动 (AF) 患者的生活质量. 这种增强的方法减少了住院时间,并改善了患者的整体幸福感.
科学领域:
- 心脏病学 心脏病学
- 临床营养学 临床营养学
- 药理学 药理学是指药理学的学科.
背景情况:
- 前庭动 (AF) 的管理需要有效的治疗策略.
- 营养状况影响心脏功能和AF患者的结果.
- 埃斯莫洛尔化是AF的关键治疗方法.
研究的目的:
- 为了评估营养支持和埃斯莫洛尔化在AF患者的联合效果.
- 为了比较标准护理与增强护理 (营养干预+皮肤护理) 在AF管理中的有效性.
- 评估对心脏功能,营养状况和生活质量的影响.
主要方法:
- 回顾性队列研究 (2021年2月至2024年2月).
- 两个组:治疗组 (TG) 提供标准护理+埃斯莫洛尔化物;护理组 (NG) 提供增强护理+埃斯莫洛尔化物.
- 临床疗效,心脏功能 (LVEF,LVESV),营养标志物 (白蛋白,总蛋白,PNI) 和生活质量的比较.
主要成果:
- 埃斯莫洛尔化单疗显示>90%的疗效,但营养护理并没有显著改善整体临床结果 (P=0.249).
- 综合营养护理显著减少了住院时间.
- 增强护理改善了左心室喷射分数 (LVEF),减少了左心室末缩体积 (LVESV),改善了营养指标 (白蛋白,总蛋白质,预后营养指数).
- 在联合干预组中,护理满意度和生活质量明显改善.
结论:
- 与埃斯莫洛尔化结合的营养护理为AF患者提供了卓越的益处.
- 这种综合方法可以提高心脏功能,营养状况和患者的生活质量.
- 这些发现支持将营养干预措施纳入AF管理协议.
相关概念视频
01:30Heart Failure V: Medical Management
198
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
198
01:22Heart Failure VI: Adjunct Therapies
235
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
235
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
879
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
879
01:26Atherosclerosis III: Management
293
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
293
01:22Heart Failure Drugs: β-Blockers
729
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
729
01:29Cardiomyopathy VI: Nursing Management
296
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
296